Participation in phase 1 trials for patients with cancer Participation in phase 1 trials for patients with cancerjulia fernandez2022-09-26T13:54:40+02:0026 septembre 2022|Publications Sarcomes|
Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohortjulia fernandez2022-05-31T11:57:37+02:0031 mai 2022|Publications Sarcomes|
Public perceptions of the association between drug effectiveness and drug novelty in France during the COVID-19 pandemic Public perceptions of the association between drug effectiveness and drug novelty in France during the COVID-19 pandemicjulia fernandez2022-05-19T22:28:25+02:0019 mai 2022|Publications Microenvironnement|
The Give-and-Take Interaction Between the Tumor Microenvironment and Immune Cells Regulating Tumor Progression and Repression The Give-and-Take Interaction Between the Tumor Microenvironment and Immune Cells Regulating Tumor Progression and Repressionjulia fernandez2022-04-13T18:45:09+02:0013 avril 2022|Publications Microenvironnement|
Does Inflammation Contribute to Cancer Incidence and Mortality during Aging ? A Conceptual Review Does Inflammation Contribute to Cancer Incidence and Mortality during Aging ? A Conceptual Reviewjulia fernandez2022-03-29T13:20:22+02:0029 mars 2022|Publications Oncogeriatrie|
Exploring Determinants of Interdisciplinary Collaboration within a Geriatric Oncology Setting: A Mixed-Method Study Exploring Determinants of Interdisciplinary Collaboration within a Geriatric Oncology Setting: A Mixed-Method Studyjulia fernandez2022-03-23T09:47:12+01:0018 mars 2022|Publications Oncogeriatrie|
